Anxious distress is associated with increased immune dysregulation in patients with major depressive disorder

被引：0
|
作者：
Gaspersz, R. [1 ]
Lamers, F. [1 ]
Wittenberg, G. [2 ]
Beekman, A. [1 ]
van Hemert, A. [3 ]
Schoevers, R. [4 ]
Penninx, B. [1 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Psychiat, Amsterdam, Netherlands
[2] Janssen Res & Dev LLC, Neurosci, Raritan, NJ USA
[3] Leiden Univ, Med Ctr, Psychiat, Leiden, Netherlands
[4] Univ Med Ctr Groningen, Psychiat, Groningen, Netherlands
来源：
EUROPEAN PSYCHIATRY | 2017年 / 41卷
关键词：
D O I：
10.1016/j.eurpsy.2017.01.2028
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EW0159
引用
收藏
页码：S158 / S158
页数：1
相关论文
共 50 条
  • [1] The role of anxious distress in immune dysregulation in patients with major depressive disorder
    Gaspersz, Roxanne
    Lamers, Femke
    Wittenberg, Gayle
    Beekman, Aartjan T. F.
    van Hemert, Albert M.
    Schoevers, Robert A.
    Penninx, Brenda W. J. H.
    TRANSLATIONAL PSYCHIATRY, 2017, 7
  • [2] The role of anxious distress in immune dysregulation in patients with major depressive disorder
    Roxanne Gaspersz
    Femke Lamers
    Gayle Wittenberg
    Aartjan T. F. Beekman
    Albert M. van Hemert
    Robert A. Schoevers
    Brenda W. J. H. Penninx
    Translational Psychiatry, 7
  • [3] LUMATEPERONE IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER AND BIPOLAR DISORDER WITH ANXIOUS DISTRESS AND MIXED FEATURES
    Bhagwagar, Zubin
    Kozauer, Susan G.
    Earley, Willie R.
    Huo, Jason
    Sachs, Gary S.
    Durgam, Suresh
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i316 - i316
  • [4] Lumateperone in the Treatment of Patients With Major Depressive Disorder and Bipolar Disorder With Anxious Distress and Mixed Features
    Durgam, Suresh
    Kozauer, Susan G.
    Earley, Willie R.
    Huo, Jason
    Mates, Sharon
    Sachs, Gary S.
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 199 - 200
  • [5] Lumateperone in the treatment of patients with major depressive disorder and bipolar disorder with anxious distress and mixed features
    Durgam, Suresh
    Kozauer, Susan G.
    Earley, Willie R.
    Huo, Jason
    Loo, Bradford
    Sachs, Gary S.
    BIPOLAR DISORDERS, 2024, 26 : 130 - 130
  • [6] Effects of Adjunctive Brexpiprazole on Individual Depressive Symptoms and Functioning in Patients With Major Depressive Disorder and Anxious Distress
    McIntyre, Roger S.
    Bubolic, Suzy
    Zhang, Zhen
    MacKenzie, Erin M.
    Therrien, Francois
    Miguelez, Maia
    Boucher, Matthieu
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2024, 44 (02) : 133 - 140
  • [7] Immune system dysregulation in adolescent major depressive disorder
    Gabbay, Vilma
    Klein, Rachel G.
    Alonso, Carmen M.
    Babb, James S.
    Nishawala, Melissa
    De Jesus, Georgette
    Hirsch, Glenn S.
    Hottinger-Blanc, Pauline M. Z.
    Gonzalez, Charles J.
    JOURNAL OF AFFECTIVE DISORDERS, 2009, 115 (1-2) : 177 - 182
  • [8] Validity of the DSM-5 anxious distress specifier for major depressive disorder
    Zimmerman, Mark
    Martin, Jacob
    McGonigal, Patrick
    Harris, Lauren
    Kerr, Sophie
    Balling, Caroline
    Kiefer, Reina
    Stanton, Kasey
    Dalrymple, Kristy
    DEPRESSION AND ANXIETY, 2019, 36 (01) : 31 - 38
  • [9] Grades of hematopoietic distress in major depressive disorder patients associated with suicidal attempt
    Velasco, A.
    Martinez-Botia, P.
    Rodriguez-Revuelta, J.
    Abad, I.
    De la Fuente-Tomas, L.
    Arias, T.
    Munoz-Turillas, M.
    Gutierrez, L.
    Garcia-Portilla, M. P.
    Bobes, J.
    Saiz Martinez, P. A.
    EUROPEAN PSYCHIATRY, 2019, 56 : S309 - S310
  • [10] Hematochezia caused by tandospirone in a patient with major depressive disorder and anxious distress: a case report
    Jiang, Xingmei
    Ma, Zhongrui
    Li, Zhixiong
    Ou, Ying
    Luo, Zhenhua
    Li, Zhe
    FRONTIERS IN PSYCHIATRY, 2023, 14
12345